Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 62756-461

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 62756-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa-structure (Carbidopa Structure)

Carbidopa-structure (Carbidopa Structure)
Chemical structure diagram depicting the molecular formula of the active ingredient in the CARBIDOPA AND LEVODOPA combination. The structure includes functional groups such as hydroxyl and carboxyl, and shows the molecule's composition with associated hydrazine and water components.*
FDA Label Image

Cdld-label-25mg-100mg (Cdld Label 25mg 100mg)

Cdld-label-25mg-100mg (Cdld Label 25mg 100mg)
Label for Carbidopa and Levodopa extended-release oral tablets with strengths of 25 mg Carbidopa and 100 mg Levodopa. The package contains 30 tablets and is distributed by Sun Pharmaceutical Industries, Inc. Storage instructions and dispensing information are also provided.*
FDA Label Image

Cdld-label-50mg-200mg (Cdld Label 50mg 200mg)

Cdld-label-50mg-200mg (Cdld Label 50mg 200mg)
Label for Carbidopa and Levodopa extended-release tablets, 50 mg/200 mg strength, by Sun Pharmaceutical Industries, Inc. The label indicates a container of 30 tablets, with storage and dispensing instructions, including temperature guidelines and child-resistant closure. The label also features the Sun Pharma logo and manufacturing details in Gujarat, India.*
FDA Label Image

Levodopa-structure (Levodopa Structure)

Levodopa-structure (Levodopa Structure)
Chemical structure of the active ingredient shown as a molecular diagram featuring a benzene ring with hydroxyl groups, a side chain with an amino group, and a carboxyl group, representing the compound in CARBIDOPA AND LEVODOPA extended release tablets by Sun Pharmaceutical Industries, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.